Macquarie Group
ACOR

Macquarie Group’s Acorda Therapeutics ACOR Stock Holding History

Macquarie Group’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20
Closed -$37K – 2140
2018
Q4 		$37K Sell
20
-15
-43% -$32.6K ﹤0.01% 1660
2018
Q3 		$83K Buy
35
+21
+150% +$65K ﹤0.01% 1625
2018
Q2 		$49K Sell
14
-1
-7% -$3.06K ﹤0.01% 1952
2018
Q1 		$43K Buy
15
+12
+400% +$35.9K ﹤0.01% 2004
2017
Q4 		$6K Sell
3
-5,695
-100% -$16.2M ﹤0.01% 2340
2017
Q3 		$16.2M Buy
5,698
+689
+14% +$1.82M 0.03% 497
2017
Q2 		$11.8M Buy
5,009
+679
+16% +$1.35M 0.02% 567
2017
Q1 		$10.9M Sell
4,330
-1,097
-20% -$3.16M 0.02% 597
2016
Q4 		$12.2M Buy
5,427
+378
+7% +$899K 0.02% 562
2016
Q3 		$12.7M Sell
5,049
-4,588
-48% -$13.7M 0.02% 547
2016
Q2 		$29.5M Buy
9,637
+5,861
+155% +$19.1M 0.03% 466
2016
Q1 		$12M Buy
3,776
+304
+9% +$1.26M 0.02% 495
2015
Q4 		$17.8M Sell
3,472
-296
-8% -$1.29M 0.04% 383
2015
Q3 		$12M Buy
3,768
+766
+26% +$2.97M 0.03% 466
2015
Q2 		$12M Buy
3,002
+455
+18% +$1.76M 0.02% 476
2015
Q1 		$10.2M Buy
2,547
+728
+40% +$3.33M 0.02% 546
2014
Q4 		$8.92M Buy
1,819
+285
+19% +$1.22M 0.02% 552
2014
Q3 		$6.24M Buy
1,534
+338
+28% +$1.27M 0.01% 639
2014
Q2 		$4.84M Buy
1,196
+141
+13% +$575K 0.01% 714
2014
Q1 		$4.8M Buy
1,055
+276
+35% +$1.12M 0.01% 684
2013
Q4 		$2.73M Buy
779
+75
+11% +$292K ﹤0.01% 856
2013
Q3 		$2.9M Sell
704
-28
-4% -$121K 0.01% 780
2013
Q2 		$2.9M Buy
+732
New +$3.01M 0.01% 748

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Macquarie Group's ACOR Position: Q1 2019 in Review

Macquarie Group sold out of Acorda Therapeutics (ACOR) in Q1 2019, closing a stake of 20 shares — an estimated $37K sold.

Macquarie Group first reported a position in ACOR in Q2 2013 and held it in 23 quarters. The position peaked at $29.5M in Q2 2016. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

  • Macquarie Group reported no remaining Acorda Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Macquarie Group sold 20 Acorda Therapeutics shares in Q1 2019, an estimated $37K.
  • Macquarie Group first reported a position in Acorda Therapeutics in Q2 2013 and held it in 23 quarters.
  • Macquarie Group's Acorda Therapeutics position peaked at $29.5M in Q2 2016.
  • 184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.